Literature DB >> 24108569

Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: a preliminary study of the correlations between quantitative parameters and clinical stage.

Dechun Zheng1, Yunbin Chen, Ying Chen, Luying Xu, Weibo Chen, Yiqi Yao, Zhongshi Du, Xiaohong Deng, Queenie Chan.   

Abstract

PURPOSE: To evaluate the relationship between quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and clinical stage of nasopharyngeal carcinoma (NPC).
MATERIALS AND METHODS: Fifty-one newly diagnosed NPC patients received MRI examination on Philips Achieva 3.0 Tesla TX MR system. We used DCE-Tool (Philips Healthcare, Best, The Netherlands) to investigate parameters from primary tumors. Tumor/node/metastasis and corresponding clinical stages were determined based on 2009 UICC 7th edition. The correlations between quantitative parameters and clinical stage were correlated using Pearson correlation analysis.
RESULTS: Mean K(trans) , Kep , ve , and vp for primary tumors were 0.500 ± 0.188/min, 0.744 ± 0.273/min, 0.986 ± 0.595, and 0.052 ± 0.071, respectively. Both K(trans) and Kep of tumors showed moderate negative correlation with clinical stage, T stage and N stage (P < 0.05), while ve showed moderate positive correlation with them (P < 0.05). vp revealed a moderate negative correlation with T stage (r = -0.369; P < 0.004). Kep and ve have significant differences between many early and advanced stages patients.
CONCLUSION: DCE-MRI is feasible to assess vascular permeability of NPC patients. Our results first revealed that the quantitative parameters were significantly related to clinical stage of NPC. Thus, DCE-MRI may be valuable to add noninvasive prognostic indicators in evaluating NPC.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  DCE-MRI; clinical staging; hypoxia; nasopharyngeal carcinoma

Mesh:

Substances:

Year:  2013        PMID: 24108569     DOI: 10.1002/jmri.24249

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  14 in total

1.  Usefulness of dynamic contrast-enhanced magnetic resonance imaging for predicting treatment response to vinorelbine-cisplatin with or without recombinant human endostatin in bone metastasis of non-small cell lung cancer.

Authors:  Rui Zhang; Zhi-Yu Wang; Yue-Hua Li; Yao-Hong Lu; Shuai Wang; Wen-Xi Yu; Hui Zhao
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  Dynamic contrast-enhanced MRI of oral squamous cell carcinoma: a preliminary study of the correlations between quantitative parameters and the clinical stage.

Authors:  T Chikui; E Kitamoto; Y Kami; S Kawano; K Kobayashi; T Kamitani; M Obara; K Yoshiura
Journal:  Br J Radiol       Date:  2015-04-23       Impact factor: 3.039

3.  Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.

Authors:  J Y Yu; D Zhang; X L Huang; J Ma; C Yang; X J Li; H Xiong; B Zhou; R K Liao; Z Y Tang
Journal:  J Med Syst       Date:  2020-02-26       Impact factor: 4.460

4.  Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nadia Nada
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-27       Impact factor: 2.503

5.  Contrast-enhanced dynamic and diffusion-weighted magnetic resonance imaging at 3.0 T to assess early-stage nasopharyngeal carcinoma.

Authors:  Liangping Ni; Ying Liu
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

6.  Application of integrated positron emission tomography/magnetic resonance imaging in evaluating the prognostic factors of head and neck squamous cell carcinoma with positron emission tomography, diffusion-weighted imaging, dynamic contrast enhancement and combined model.

Authors:  Haodan Dang; Yu Chen; Zhuhua Zhang; Xiaohua Shi; Xingming Chen; Xiaoli Zhu; Bo Hou; Haiqun Xing; Huadan Xue; Zhengyu Jin
Journal:  Dentomaxillofac Radiol       Date:  2020-04-03       Impact factor: 2.419

7.  Intravoxel Incoherent Motion-Magnetic Resonance Imaging as an Early Predictor of Treatment Response to Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.

Authors:  Youping Xiao; Jianji Pan; Yunbin Chen; Ying Chen; Zhuangzhen He; Xiang Zheng
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

8.  DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin.

Authors:  Xilin Sun; Lili Yang; Xuefeng Yan; Yingying Sun; Dongliang Zhao; Yang Ji; Kai Wang; Xiaoyuan Chen; Baozhong Shen
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

9.  Consistency of T2WI-FS/ASL fusion images in delineating the volume of nasopharyngeal carcinoma.

Authors:  Meng Lin; Xiaoduo Yu; Han Ouyang; Dehong Luo; Chunwu Zhou
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

10.  Associations between 18F-FDG-PET, DWI, and DCE Parameters in Patients with Head and Neck Squamous Cell Carcinoma Depend on Tumor Grading.

Authors:  Leonard Leifels; Sandra Purz; Patrick Stumpp; Stefan Schob; Hans Jonas Meyer; Thomas Kahn; Osama Sabri; Alexey Surov
Journal:  Contrast Media Mol Imaging       Date:  2017-10-19       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.